갈륨 니트레이트

갈륨 니트레이트
갈륨 니트레이트 구조식 이미지
카스 번호:
13494-90-1
한글명:
갈륨 니트레이트
동의어(한글):
갈륨니트레이트;갈륨니트레이트
상품명:
GALLIUM NITRATE
동의어(영문):
ganite;nsc-15200;Ga(NO3)3nH2O;Ga(NO3)3?5H2O;Wln: ga N-o3*3;GALLIUM NITRATE;galliumtrinitrate;Gallium(Ⅲ) nitrate;GALLIUM (III) NITRATE;Nitricacid,galliumsalt
CBNumber:
CB3209552
분자식:
GaH4NO3
포뮬러 무게:
135.76
MOL 파일:
13494-90-1.mol
MSDS 파일:
SDS

갈륨 니트레이트 속성

녹는점
110°C (dec.)
용해도
soluble in H2O, ethanol, ethyl ether
물리적 상태
액체
색상
white crystals, crystalline powder
수용성
물에 용해됩니다.
노출 한도
ACGIH: TWA 2 ppm; STEL 4 ppm
OSHA: TWA 2 ppm(5 mg/m3)
NIOSH: IDLH 25 ppm; TWA 2 ppm(5 mg/m3); STEL 4 ppm(10 mg/m3)
InChI
1S/Ga.3NO3/c;3*2-1(3)4/q+3;3*-1
InChIKey
CHPZKNULDCNCBW-UHFFFAOYSA-N
SMILES
[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
EPA
Gallium nitrate (13494-90-1)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험 카페고리 넘버 8-36/37/38
안전지침서 17-26-36/37/39
유엔번호(UN No.) 1477
WGK 독일 WGK 3
TSCA TSCA listed
위험 등급 5.1
포장분류 III
스토리지 클래스 5.1B - Oxidizing hazardous materials
Hazard Classifications Eye Irrit. 2
Ox. Liq. 2
Skin Irrit. 2
기존화학 물질 KE-17446
그림문자(GHS): Flame Over Circle (GHS03)Exclamation Mark (GHS07)
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H272 화재를 강렬하게 함; 산화제 산화성 액체;산화성 고체 구분 2
구분 3
위험
경고
P210, P220, P221P280, P370+P378,P501
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 P264, P280, P302+P352, P321,P332+P313, P362
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 P264, P280, P305+P351+P338,P337+P313P
예방조치문구:
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P302+P352 피부에 묻으면 다량의 물로 씻으시오.
P305+P351+P338 눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.
P332+P313 피부 자극이 생기면 의학적인 조치· 조언을 구하시오.
P337+P313 눈에 대한 자극이 지속되면 의학적인 조치· 조언를 구하시오.
NFPA 704
0
4 0

갈륨 니트레이트 C화학적 특성, 용도, 생산

개요

Gallium nitrate, initially developed as an anticancer agent, was introduced by Fujisawa as an orphan drug for the treatment of cancer-related hypercalcemia and bone metastases that do not respond to adequate hydration. The compound acts specifically on bone by inhibiting calcium resorption and also possibly by stimulating bone formation. Compared with calcitonin and etidronate, gallium nitrate is more potent and substantially longer acting. Other potential uses could be in the treatment of osteoporosis and Paget’s disease.

화학적 성질

The structural formula of gallium nitrate is Ga(NO3)3. Gallium nitrate is an anhydrate salt that is very soluble in water and soluble in 95% ethanol. It is stable in commonly used intravenous fluids for 14 days at room temperature and at 5 ℃, and physically compatible for injection with selected drug products, with the exception of diazepam injection.This chemical is an oxidizer, and is probably combustible

용도

Gallium is the second metal ion with clinical activity used in cancer treatment. Gallium nitrate has demonstrated antitumor activity in a variety of murine tumor models, including Walker 256 carcinosarcoma, fibrosarcoma M-89, leukemia K-1964, adenocarcinoma 755, mammary carcinoma YMC, reticulum cell sarcoma A-RCS, lymphoma P1798, and osteosarcoma 124F. It was, however, ineffective in ascites, leukemias, plasma cell tumors, or Ehrlich carcinoma. In phase II evaluation studies, gallium nitrate has shown antitumor activity in patients with either refractory lymphomas or small-cell lung carcinomas or bladder cancer, with total objective response rates of 28% and 11%, respectively. This drug has displayed its strongest antineoplastic activity in the treatment of non-Hodgkin’s lymphoma and bladder cancer.
In addition, according to two phase III comparative trials,thanks to an inhibitory effect on calcium reabsorption from bone, gallium nitrate is superior to alternative therapies in the treatment of hypercalcemia associated with malignancy and related disease states. Based on its clinical efficacy, gallium nitrate (Ganite ) was approved by the Food and Drug Administration (FDA) for the treatment of cancerassociated hypercalcemia.
Apart from its ability to control hypercalcemia, gallium nitrate has been shown to inhibit bone turnover and decrease osteolysis in patients with multiple myeloma and in patients with bone metastases from a variety of different cancers.

일반 설명

White crystals.

공기와 물의 반응

Deliquescent. Water soluble.

반응 프로필

Oxidizing agents, such as GALLIUM NITRATE, can react with reducing agents to generate heat and products that may be gaseous (causing pressurization of closed containers). The products may themselves be capable of further reactions (such as combustion in the air). The chemical reduction of materials in this group can be rapid or even explosive, but often requires initiation (heat, spark, catalyst, addition of a solvent). Explosive mixtures of inorganic oxidizing agents with reducing agents often persist unchanged for long periods if initiation is prevented. Such systems are typically mixtures of solids, but may involve any combination of physical states. Some inorganic oxidizing agents are salts of metals that are soluble in water; dissolution dilutes but does not nullify the oxidizing power of such materials. Organic compounds, in general, have some reducing power and can in principle react with compounds in this class. Actual reactivity varies greatly with the identity of the organic compound. Inorganic oxidizing agents can react violently with active metals, cyanides, esters, and thiocyanates.

화재위험

Flash point data for GALLIUM NITRATE are not available, but GALLIUM NITRATE is probably combustible.

Pharmaceutical Applications

In clinical trials, gallium nitrate has proved to be highly active as an antitumour agent especially against non-Hodgkin’s lymphoma and bladder cancer. The cytotoxic activity of gallium nitrate has been demonstrated as single agent and as part of combination therapy, for example, together with fluorouracil. Gallium nitrate shows a relatively low toxicity and does not produce myelosuppression, which is a significant advantage over other traditional anticancer agents. Furthermore, it does not appear to show any cross-resistance with conventional chemotherapeutic agents.
These studies have also shown that gallium nitrate is able to decrease serum calcium levels in patients with tumour-induced hypercalcaemia. Subsequently, several studies have been carried out comparing traditional bisphosphonate drugs with gallium nitrate in their ability to decrease the calcium levels that are elevated as a result of cancer. Based on the clinical efficacy, gallium nitrate injections (GaniteTM) was granted approval by the FDA for the treatment of cancer-associated hypercalcaemia. Gallium nitrate is also believed to inhibit the bone turnover and therefore to decrease osteolysis, the active reabsorption of bone material, in patients with bone metastasis secondary to other cancers.

Carcinogenicity

Studies on the antitumor activity of gallium nitrate have shown that it is particularly active against solid tumors. It has demonstrated antitumor activity in a variety of murine tumor models, including Walker carcinosarcoma 256, fibrosarcoma M-89, leukemia K-1964, adenocarcinoma 755, mammary carcinoma YMC, reticulum cell sarcoma A-RCS, lymphoma P1798, and osteosarcoma 124F.

갈륨 니트레이트 준비 용품 및 원자재

원자재

준비 용품


갈륨 니트레이트 공급 업체

글로벌( 73)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Meryer (Shanghai) Chemical Technology Co., Ltd. 4006356688 18621169109
market03@meryer.com China 40202 62
Alfa Aesar 400-6106006
saleschina@alfa-asia.com China 30103 84
Shandong Xiya Chemical Co., Ltd 13355009207 13355009207
3007715519@qq.com China 18722 57
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12323 58
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-6206333 13167063860
anhua.mao@aladdin-e.com China 29977 65
HBCChem, Inc. +1-510-219-6317
sales@hbcchem.com United States 10628 60
Shandong Xiya Chemical Co., Ltd. 4009903999 13395398332
sales@xiyashiji.com China 20788 60
Guangdong wengjiang Chemical Reagent Co., Ltd. 0751-2886750 13927877953
3005811397@qq.com China 13281 58
Shanghai Orgchem Co.,Ltd. +86-21-5877 1921
info@chemofchina.com China 9630 55
Shandong Ono Chemical Co., Ltd. 0539-6362799 20)
China 9998 58

갈륨 니트레이트 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved